Richards, Merrill & Peterson, Inc. Bristol Myers Squibb CO Transaction History
Richards, Merrill & Peterson, Inc.
- $232 Billion
- Q3 2025
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 6,803 shares of BMY stock, worth $318,448. This represents 0.13% of its overall portfolio holdings.
Number of Shares
6,803
Previous 7,348
7.42%
Holding current value
$318,448
Previous $340 Million
9.8%
% of portfolio
0.13%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,684Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...